Showing 1 - 3 results of 3 for search 'M. Simkovic', query time: 0.02s Refine Results
  1. 1
    Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies

    Antibodies against Pneumococcal Capsular Polysaccharides and Natural Anti-Galactosyl (Alpha-Gal) in Patients with Humoral Immunodeficiencies by P. Kralickova, J. Kuhnova, O. Soucek, P. Vodarek, P. Zak, M. Simkovic, M. Motyckova, L. Smolej, E. Mala, C. Andrys, J. Krejsek, V. Thon

    Published 2017-01-01
    Get full text
    Article
  2. 2
    P676: LOW-DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CLL STUDY GROUP.

    P676: LOW-DOSE FCR COMPARED TO BR IN PREVIOUSLY UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT TP53 ABERRATIONS: A REAL – WORLD RETROSPECTIVE ANALYSIS BY THE CZECH CL... by L. Smolej, Y. Brychtová, E. Cmunt, M. Oršulová, P. Vodárek, M. Dostál, P. Turcsányi, R. Urbanová, A. Panovská, J. Zuchnická, J. Mihályová, D. Lysák, M. Brejcha, H. Móciková, K. Klásková, M. Šimkovič, M. Špaček, M. Doubek

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP

    P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP by P. Ghia, A. Pluta, M. Wach, D. Lysak, M. Simkovic, I. Kriachok, A. Illes, J. de la Serna, S. Dolan, P. Campbell, G. Musuraca, A. Jacob, E. Avery, J. H. Lee, G. Usenko, M. H. Wang, T. Yu, W. Jurczak

    Published 2022-06-01
    Get full text
    Article

Search Tools: